Participants 79 121 4
men receiving therapy for prostate cancer.
Participants 611 672 4
men receiving androgen deprivation for their prostate cancer.
Participants 1166 1342 7
Multi-site randomized controlled trial of 195 men (65 subjects per arm) undergoing treatment for prostate cancer involving ADT in the cities of Perth and Brisbane in Australia.
